BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1776828)

  • 1. Hyperthermia potentiates the cytotoxic activity of 1-hexylcarbamoyl-5-fluorouracil in sarcoma-180 cells and human malignant tumor cells.
    Kusumoto T; Maehara Y; Sakaguchi Y; Kohnoe S; Sugimachi K
    Anticancer Res; 1991; 11(6):1963-6. PubMed ID: 1776828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil.
    Kusumoto T; Maehara Y; Sakaguchi Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):477-81. PubMed ID: 2703002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
    Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro.
    Tsumura M; Yoshiga K; Takada K
    Cancer Res; 1988 Jul; 48(14):3977-80. PubMed ID: 3383192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thermochemotherapy [1-hexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo.
    Sakurai K; Yoshiga K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(5A):2729-33. PubMed ID: 8917379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
    Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
    Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K
    Dis Colon Rectum; 1988 Jan; 31(1):62-7. PubMed ID: 3130239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
    Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
    Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
    Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
    Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
    Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
    Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
    Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate on 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil in mice bearing ascites sarcoma 180.
    Iigo M; Kuretani K; Hoshi A
    J Natl Cancer Inst; 1981 Feb; 66(2):345-9. PubMed ID: 6935483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Hexylcarbamoyl-5-fluorouracil alters the expression of heat shock protein in HeLa cells.
    Kusumoto T; Maehara Y; Sakaguchi Y; Emi Y; Kohnoe S; Sugimachi K
    Anticancer Drugs; 1991 Feb; 2(1):45-8. PubMed ID: 1958851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil.
    Nakanishi H; Abe A; Inada K; Tsukamoto T; Yasui K; Tatematsu M
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):660-8. PubMed ID: 10592098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of metabolites of 1-hexylcarbamoyl-5-fluorouracil and related compounds against L1210 leukemia in vivo and L5178Y lymphoma cells in vitro.
    Hoshi A; Yoshida M; Inomata M; Iigo M; Ando N; Kuretani K
    J Pharmacobiodyn; 1980 Sep; 3(9):478-81. PubMed ID: 7463306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil.
    Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Chemother Pharmacol; 1980; 4(2):83-7. PubMed ID: 7389060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humans.
    Emi Y; Kohnoe S; Yoshida M; Takahashi I; Maehara Y; Sugimachi K
    Cancer; 1992 Sep; 70(5):1177-82. PubMed ID: 1515994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.
    Maehara Y; Sakaguchi Y; Takahashi I; Yoshida M; Kusumoto H; Masuda H; Sugimachi K
    Cancer Chemother Pharmacol; 1992; 29(4):257-60. PubMed ID: 1537070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of HCFU and TNP 470 on liver metastasis of BALB/c retroperitoneal sarcoma (LMFS)].
    Fujii Y; Iwasa H; Hirai J; Hasumi K; Eriguchi M
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2061-7. PubMed ID: 10584572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.